Clinical Trials Browser

Phase EARLY_PHASE1 × Carcinoma, Hepatocellular × Bevacizumab × Clear all

NCT04857684 2025-10-01

SBRT + Atezolizumab + Bevacizumab in Resectable HCC

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular